MXD4 anticorps (C-Term)

N° du produit ABIN184842

Cet anticorps anti-MXD4 est un anticorps Chèvre Polyclonal détectant MXD4 dans ELISA et WB. Adapté pour Humain.

Aperçu rapide pour MXD4 anticorps (C-Term) (ABIN184842)

Antigène: MXD4 (MAX Dimerization Protein 4 (MXD4))

Reactivité: Humain

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp MXD4 est non-conjugé

Application: ELISA, Western Blotting (WB)

Classe de qualité: Verified

Détail du produit anti-MXD4 anticorps

Épitope: C-Term

Fonction: MAD4 / MXD4

Séquence: GPHCRRLGRP ALS

Réactivité croisée: Humain

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Immunogène: Peptide with sequence GPHCRRLGRPALS, from the C Terminus of the protein sequence according to NP_006445.1.

Isotype: IgG

Information d'application

Indications d'application:

Western Blot: Approx 22 kDa band observed in human kidney lysates (predicted MW of 24 kDa according to NP_006445). Recommended for use at 0.5-2 μg/mL. Please note the appearance of this band was blocked by incubation with the immunising peptide.

Peptide ELISA: antibody detection limit dilution 1:16000.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Minimize freezing and thawing.

Stock: -20 °C

Stockage commentaire: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Détails sur MXD4

Antigène: MXD4 (MAX Dimerization Protein 4 (MXD4))

Autre désignation: MXD4

Sujet: MXD4, MAD4, MAX dimerization protein 4, Mad4 homolog, MST149, MSTP149, bHLHc12

ID gène: 10608

NCBI Accession: NP_006445